Oncology - European Medical Journal

Continue

Oncology

Filter
13 Mins
12 Apr 2022

Clinical Implications of Emerging Metastatic Breast Cancer Data from ESMO 2021: Interviews with Two Key Opinion Leaders

Around 15–20% of breast cancers are characterised by amplification or overexpression of human epidermal growth factor receptor 2 (HER2)…
4 Mins
7 Apr 2022

Dual Immunotherapy in a Patient with Rapidly Progressive Metastatic Melanoma Without Failure of Grafted Kidney

Melanoma is the third most common skin cancer in the UK. Checkpoint inhibitors (CPI) have revolutionised the treatment of melanoma.
EMJ 7.1 2022 Feature Image
10 Mins
22 Mar 2022

Utility of Evidence-Based Clinical Decision Support in Reducing Unwarranted Variations in Diagnosis and Treatment of Breast and Lung Cancer

It is clear that the delivery of advanced healthcare prolongs life. The global average life expectancy has almost doubled since 1900…
EMJ 7.1 2022 Feature Image
5 Mins
22 Mar 2022

Ewing’s Sarcoma of the Lung as a Second Malignancy in Long-Term Survivor of Childhood Hodgkin’s Lymphoma: A Rare Case Report and Literature Review

Long-term survivors of lymphoma frequently suffer relapses, such as Ewing’s sarcoma, following radiotherapy and chemotherapy…
EMJ Oncology 10 [Supplement 6] 2022 Feature Image
13 Mins
21 Mar 2022

Multidisciplinary Team Approach in Cancer Care: A Review of the Latest Advancements Featured at ESMO 2021

A collaborative approach from healthcare professionals is necessary for the management of patients with cancer to diagnose and treat…
EMJ Oncology 10 [Supplement 5] 2022 Feature Image
8 Mins
7 Mar 2022

Implementation of MET Molecular Testing in the Clinic: Latest Evidence for Mesenchymal–Epithelial Transition Inhibitors in Non-small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is a heterogeneous disease with many genomic mutations. Furthermore, comprehensive genomic…
EMJ Oncology 10 [Supplement 4] 2022 Feature Image
7 Mins
24 Feb 2022

Evolving the Role for Immunotherapy in Lung Cancer: Extensive-Stage Small Cell Lung Cancer and Unresectable Stage III Non-small Cell Lung Cancer

Lung cancer is classified into NSCLC (85% of patients) and SCLC (15%). NSCLC can be further classified histologically into three main type…
11 Mins
18 Feb 2022

New Developments, Data, and Guideline Updates: Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism Associated with Cancer – Interviews with Key Opinion Leaders

CAT is a serious complication that can affect up to 6% of patients with cancer, and is associated with a 2–5-fold increased risk of…